RecruitingNCT03566797
Rare condition
Secondary sclerosing cholangitis
1
studies recruiting now
as of 7 Sept 2026
5
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
25 Jun 2018
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Secondary sclerosing cholangitis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Secondary sclerosing cholangitis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Secondary sclerosing cholangitis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
33 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Cilofexor
Phase 3Norucholic Acid
Phase 3Simvastatin (Flolipid)
Phase 3Vancomycin
Phase 2/3Ursodiol (Actigall)
Phase 2/3Aldafermin
Phase 2Obeticholic Acid (Ocaliva)
Phase 2Aramchol Meglumine
+ 25 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).